Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Accuray Incorporated (ARAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 344,040
  • Shares Outstanding, K 86,660
  • Annual Sales, $ 404,900 K
  • Annual Income, $ -23,900 K
  • 36-Month Beta 1.52
  • Price/Sales 0.83
  • Price/Cash Flow N/A
  • Price/Book 7.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.06
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.16 +39.65%
on 12/26/18
4.61 -4.12%
on 01/23/19
+1.03 (+30.38%)
since 12/21/18
3-Month
3.16 +39.65%
on 12/26/18
5.30 -16.60%
on 11/07/18
+0.78 (+21.43%)
since 10/23/18
52-Week
3.16 +39.65%
on 12/26/18
6.15 -28.13%
on 01/31/18
-0.78 (-15.00%)
since 01/23/18

Most Recent Stories

More News
Watch for Accuray Inc to Potentially Pullback After Gaining 12.09% Yesterday

Accuray Inc (NASDAQ:ARAY) traded in a range yesterday that spanned from a low of $4.30 to a high of $4.58. Yesterday, the shares gained 12.1%, which took the trading range above the 3-day high of $4.06...

ARAY : 4.42 (+11.34%)
Accuray's (ARAY) Q2 Loss Narrows, Radixact Demand Shoots Up

Demand for flagship Radixact & CyberKnife platforms aids Accuray's (ARAY) fiscal Q2 results.

ARAY : 4.42 (+11.34%)
BDX : 239.14 (-0.02%)
ANGO : 20.84 (-0.48%)
ISRG : 529.95 (-1.27%)
Accuray: Fiscal 2Q Earnings Snapshot

SUNNYVALE, Calif. (AP) _ Accuray Inc. (ARAY) on Tuesday reported a loss of $4.6 million in its fiscal second quarter.

ARAY : 4.42 (+11.34%)
Accuray Reports Fiscal 2019 Second Quarter Results

Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2019 ended December 31, 2018.

ARAY : 4.42 (+11.34%)
Will Accuray (ARAY) Report Negative Earnings Next Week? What You Should Know

Accuray (ARAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ARAY : 4.42 (+11.34%)
Accuray To Report Fiscal 2019 Second Quarter Financial Results on January 22, 2019

Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2018 on Tuesday, January 22, 2019 after the market close. Management will host a conference call to review...

ARAY : 4.42 (+11.34%)
Accuray to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 9, 2019

Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will present at the J.P. Morgan 37th Annual Healthcare Conference on Wednesday, January 9, 2019 at the Westin St. Francis Hotel in San...

JPM : 102.68 (-0.25%)
ARAY : 4.42 (+11.34%)
Accuray CyberKnife® System Treatment Delivery Times Up to 50 Percent Faster With Software Upgrade

Accuray Incorporated (NASDAQ: ARAY) announced today that the new release of its Accuray Precision® Treatment Planning System (TPS) with the CyberKnife® VOLO(TM) Optimizer will enable CyberKnife System...

ARAY : 4.42 (+11.34%)
Here's Why You Should Invest in Accuray (ARAY) Stock Now

Accuray's (ARAY) benefits from growing adoption of non-surgical treatment options among cancer patients and increasing demand for its latest offerings.

ARAY : 4.42 (+11.34%)
STAA : 33.72 (-0.74%)
VEEV : 103.65 (+0.52%)
QDEL : 52.61 (+1.33%)
Accuray Appoints Shig Hamamatsu Chief Financial Officer

Accuray Incorporated (NASDAQ: ARAY) announced today that its Board of Directors has named Shig Hamamatsu as senior vice president, chief financial officer effective immediately. Mr. Hamamatsu joined Accuray...

ARAY : 4.42 (+11.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

See More Share

Trade ARAY with:

Business Summary

ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends...

See More

Key Turning Points

2nd Resistance Point 4.87
1st Resistance Point 4.65
Last Price 4.42
1st Support Level 4.16
2nd Support Level 3.89

See More

52-Week High 6.15
Fibonacci 61.8% 5.01
Fibonacci 50% 4.66
Last Price 4.42
Fibonacci 38.2% 4.31
52-Week Low 3.16

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar